Skip to content
Screener

OrthoPediatrics KIDS Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Stryker logo
StrykerSYK
$513M
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.76M+241%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$14.2M
Medtronic logo
MedtronicMDT
-$136M+11.7%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$3.07M+158%

Other financials

Income statement

See full
Revenue$70.5M+15.4%
Gross profit$52.4M+19.0%
Operating income-$4.1M+61.8%
Net income-$7.2M-0.7%
EPS (diluted)-$0.300.0%

Balance sheet

See full
Cash & equivalents$19.1M-59.1%
Total debt$4.6M+234%
Total equity$343.6M-3.3%
Total assets$511.4M+1.5%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$4.0M+17.4%
Free cash flow-$3.1M+77.6%

Valuation

See full
Market cap$594.52M+26.1%
Enterprise value$580.02M+36.0%
P/S2.4×+0.2×

Profitability

See full
Gross margin73.7%+2.1pp
Operating margin-11.9%-3.2pp
Net margin-15.7%-2.3pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.4%-0.1pp
Debt / equity0.0×
Current ratio4.8×-1.9×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: OrthoPediatrics’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 3:45 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001425450-26-000036
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Payments on acquisition notes(573)(87)
Net cash used in financing activities(614)(126)
Effect of exchange rate changes on cash, cash equivalents and restricted cash313(79)
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH(7,375)(10,348)
Cash, cash equivalents and restricted cash, beginning of year$21,620$45,777
Cash, cash equivalents and restricted cash, end of period$14,245$35,429
SUPPLEMENTAL DISCLOSURES
Cash paid for interest$1,869$1,269

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is OrthoPediatrics's net change in cash?
OrthoPediatrics (KIDS) reported net change in cash of -$7.38M in Q1 2026.
How has OrthoPediatrics's net change in cash changed year-over-year?
OrthoPediatrics's net change in cash increased by 28.7% year-over-year, from -$10.35M to -$7.38M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about OrthoPediatrics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude